“Long-Term Efficacy of Abrocitinib in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE EXTEND”. 2024. SKIN The Journal of Cutaneous Medicine 8 (1): s329. https://doi.org/10.25251/skin.8.supp.329.